Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer

被引：10
|
作者：
Xie, Xiao-Hong [1 ]
Deng, Hai-Yi [1 ]
Lin, Xin-Qing [1 ]
Wu, Jian-Hui [1 ]
Liu, Ming [1 ]
Xie, Zhan-Hong [1 ]
Qin, Yin-Yin [1 ]
Zhou, Cheng-Zhi [1 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Stale Key Lab Resp Dis,Guangzhou Inst Resp Hlth, Guangzhou, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词：
checkpoint inhibitor-related pneumonitis; nintedanib; steroid therapy; non-small cell lung cancer; pembrolizumab; IMMUNOTHERAPY;
D O I：
10.3389/fonc.2021.673877
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Pembrolizumab, an immune checkpoint inhibitor (ICI) approved for advanced non-small cell lung cancer (NSCLC) treatment, has shown superior survival benefits. However, pembrolizumab may lead to severe immune-related adverse events (irAEs), such as checkpoint inhibitor-related pneumonitis (CIP). The routine treatment of CIP was based on systemic corticosteroids, but the therapies are limited for patients who are unsuitable for steroid therapy. Here, we present the first successful treatment of nintedanib for pembrolizumab-related pneumonitis in a patient with advanced NSCLC.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report
    Niki, Maiko
    Nakaya, Aya
    Kurata, Takayasu
    Nakahama, Kahori
    Yoshioka, Hiroshige
    Kaneda, Toshihiko
    Kibata, Kayoko
    Ogata, Makoto
    Nomura, Shosaku
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (02) : 267 - 269
  • [2] Pulmonary Nocardiosis in a Non-Small Cell Lung Cancer Patient Being Treated for Pembrolizumab-Associated Pneumonitis
    Quartermain, Liam
    Buchan, C. Arianne
    Kilabuk, Elaine
    Wheatley-Price, Paul
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 1222 - 1228
  • [3] Effect of nintedanib on non-small cell lung cancer in a patient with idiopathic pulmonary fibrosis: A case report and literature review
    Shiratori, Toshihiro
    Tanaka, Hisashi
    Tabe, Chiori
    Tsuchiya, Junichiro
    Ishioka, Yoshiko
    Itoga, Masamichi
    Taima, Kageaki
    Takanashi, Shingo
    Tasaka, Sadatomo
    THORACIC CANCER, 2020, 11 (06) : 1720 - 1723
  • [4] Dynamic changes in the radiologic manifestation of a recurrent checkpoint inhibitor related pneumonitis in a non-small cell lung cancer patient: A case report
    Pei-Xin Tan
    Wei Huang
    Ping-Ping Liu
    Yi Pan
    Yan-Hai Cui
    World Journal of Clinical Cases, 2021, (30) : 9108 - 9113
  • [5] Dynamic changes in the radiologic manifestation of a recurrent checkpoint inhibitor related pneumonitis in a non-small cell lung cancer patient: A case report
    Tan, Pei-Xin
    Huang, Wei
    Liu, Ping-Ping
    Pan, Yi
    Cui, Yan-Hai
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (30) : 9108 - 9113
  • [6] Transformation of non-small cell lung cancer into small cell lung cancer in a patient with advanced lung cancer: a case report
    Yang, Zhengyuan
    Lin, Yingcheng
    Wang, Hongbiao
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (08)
  • [7] Pembrolizumab-related pneumonitis in a patient with COVID-19 infection
    Ponnalagu, Venkataganesan
    Kwan, Eng Ling Kenneth
    Sadasiv, Mucheli Sharavan
    Teo, Hui Lin
    Low, Hsien Min
    SINGAPORE MEDICAL JOURNAL, 2023, 64 (07) : 454 - 458
  • [8] Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
    Fujimoto, Daichi
    Miura, Satoru
    Tomii, Keisuke
    Sumikawa, Hiromitsu
    Yoshimura, Kenichi
    Wakuda, Kazushige
    Oya, Yuko
    Yokoyama, Toshihide
    Kijima, Takashi
    Asao, Tetsuhiko
    Tamiya, Motohiro
    Nakamura, Atsushi
    Yoshioka, Hiroshige
    Tokito, Takaaki
    Murakami, Shuji
    Tamiya, Akihiro
    Yokouchi, Hiroshi
    Watanabe, Satoshi
    Yamaguchi, Ou
    Morinaga, Ryotaro
    Jodai, Takayuki
    Ito, Kentaro
    Shiraishi, Yoshimasa
    Kogure, Yoshihito
    Shibaki, Ryota
    Yamamoto, Nobuyuki
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [9] Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
    Daichi Fujimoto
    Satoru Miura
    Keisuke Tomii
    Hiromitsu Sumikawa
    Kenichi Yoshimura
    Kazushige Wakuda
    Yuko Oya
    Toshihide Yokoyama
    Takashi Kijima
    Tetsuhiko Asao
    Motohiro Tamiya
    Atsushi Nakamura
    Hiroshige Yoshioka
    Takaaki Tokito
    Shuji Murakami
    Akihiro Tamiya
    Hiroshi Yokouchi
    Satoshi Watanabe
    Ou Yamaguchi
    Ryotaro Morinaga
    Takayuki Jodai
    Kentaro Ito
    Yoshimasa Shiraishi
    Yoshihito Kogure
    Ryota Shibaki
    Nobuyuki Yamamoto
    Scientific Reports, 13
  • [10] ENCEPHALOPATHY FOLLOWING TREATMENT WITH PEMBROLIZUMAB FOR METASTATIC NON-SMALL CELL LUNG CANCER: A CASE REPORT
    Feng, S.
    O'Byrne, K.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 54 - 54
12345